Dr Sunishtha Singh Yadav

Asst. Professor (Grade - II)

Amity Institute of Biotechnology
 
  • Qualifications

    Graduation : B.Sc.(Microbiology)-2003,Bundelkhand University

    Post Graduation : Master's in Biotechnology(Biotechnology)-2005,Allahabad Agriculture Institute

    Doctorate : Ph.D. -2010,Indian Institute of Toxicology Research (CSIR Lab), Dr. Ram Manhoar Lohia Avadh University, Faizabad

  • Experience

    08 Nov 2010 - Present
    Asst. Professor (Grade - II),
    Amity Institute of Biotechnology

    01 Apr 2010 - 30 Oct 2010
    REVIEWER ,
    AMERICAN ASSOCIATION FOR CANCER RESEARCH,
    AMERICAN ASSOCIATION FOR CANCER RESEARCH, PHILADELPHIA

    01 Jul 2009 - 15 Sep 2010
    ASSISTANT PROFESSOR,
    EMINENT BIOSCIENCES,
    EMINENT BIOSCIENCES, VIJAY NAGAR SQUARE, INDORE, MP

    01 Aug 2005 - 27 Feb 2009
    Reserach Associate,
    IITR, CSIR LAB, LKO,
    IITR, CSIR LAB, 80 MG ROAD, LKO, UP, INDIA

  • Current Courses Taught

    Biotechnology& Personalized Medicine

    Clinical Pathology and Molecular Diagnostics

    Environmental Toxicology and Health

    Innovation and Knowledge Management for Biotechnology

    Professional Ethics and Social Responsibility for Sustainability

  • Publications

    Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response. ,
    Elsevier

    Interaction of drug metabolizing Cytochrome P450 2D6 poor metabolizers with Cytochrome P450 2C9 & 2C19 genotypes modifies the susceptibility to head and neck cancer and treatment response. ,
    Elsevier

    Polymorphism of cytochrome P450 2C9, 2C19 & 2D6 and cancer susceptibility. ,
    RML University

    Association of functionally important polymorphisms of Cytochrome 450 2C19 (CYP2C19) with susceptibility to Oral cancer. ,
    Indian pharmacological society

    Functionally important polymorphism in drug metabolizing cytochrome P450s with susceptibility to head and neck cancer (HNSCC) and treatment response. ,
    International Genomic Instability and Cancer Society

    Functionally important polymorphisms in drug metabolizing cytochrome P450s with susceptibility to Head and Neck Cancer (HNSCC) and association with treatment response. ,
    Indian Pharmacology Society

    Association of PMs of CYP2C19 with HNSCC & poor treatment. ,
    Urology, China

    Association of polymorphism in Cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome. ,
    Applied and Translational Genomics

    Association of polymorphism in Cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome. ,
    Applied and Translational Genomics

    Association of polymorphism in Cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome. ,
    Applied and Translational Genomics

    Association of polymorphism in Cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome. ,
    Applied and Translational Genomics

    Association of Cytochrome P450 2D6 (CYP2D6) Polymorphisms with susceptibility to Head & Neck Squamous Cell Carcinoma & treatment response ,
    Annals of Oncology

    Pharmacogenetics & treatment outcome in cancer patients receiving radio-chemotherapy ,
    Annals of Oncology

    Pharmacogenetics of Cytochrome P450 2C9 (CYP2C9) & treatment outcome in HNSCC patients receiving radio-chemotherapy ,
    EACR

    Susceptibility to oral cancer and chemotherapeutic outcomes. ,
    Annals of Oncology

    Organophosphates Induced Alzheimer's Disease: An Epigenetic Aspect ,
    Journal of Clinical Epigenetics

    Organophosphates Induced Alzheimer’s Disease: An Epigenetic Aspect ,
    iMedPub

    Head & neck cancer pharmacogenetics: case control study on 5- fluorouracil and cisplatin adjuvant treatment outcome ,
    Annals of Oncology/Oxford press

    Breast cancer pharmacogenetics: Case control study on TAM adjuvant treatment outcome ,
    Annals of Oncology/Oxford press

  • Affiliations

    European Association for Cancer Research, Young Investigator Since 01 Oct 2014

    ESMO Since 01 Oct 2013

    International Society for Neurochemistry Since 01 Sep 2013

    ? Forensic Science Development Society Since 01 Nov 2011

  • Conferences attended

    40th Annual conference of Indian pharmacological society (IPS)
    Organized By :Indian Pharmacology Society

    International Symposium on Genomic Instability and Cancer
    Organized By :at International Genomic Instability and Cancer Society

    39th Annual conference of Indian pharmacological society (IPS)
    Organized By :Indian Pharmacology Society

    EPS Global Shanghai International Congress of Urology, Shanghai, China
    Organized By :EPS Global Society of Urology, Canada

    Neurophychology
    Organized By :ISN

    Christie Lung Cancer Course 2014
    Organized By :Christie Manchester

    Prostate Cancer
    Organized By :European Society

    Radiation Biology
    Organized By :European Cancer Society

    Cancer
    Organized By :European Cancer Society